Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph early_phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT06337812
completednot_applicable

Fiber Supplementation After Bariatric Surgery

NCT05653648
completedearly_phase_1

Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors

NCT04552418
completednot_applicable

Oligosaccharide for Cdiff(+) Heme-onc Patients

NCT03778606

Clinical Trials (4)

Showing 4 of 4 trials
NCT06337812Not Applicable

Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)

Recruiting
NCT05653648Not Applicable

Fiber Supplementation After Bariatric Surgery

Completed
NCT04552418Early Phase 1

Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors

Completed
NCT03778606Not Applicable

Oligosaccharide for Cdiff(+) Heme-onc Patients

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4